Buprenorphine implants: a model for expedited development and approval of new drugs-Reference-Cited by-同舟云学术

Buprenorphine implants: a model for expedited development and approval of new drugs

Published:2020-11-24 Issue:1 Volume:37 Page:83-88
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Guarnieri Michael¹,Kedda Jayanidhi¹,Tyler Betty¹

Affiliation:

1. Department of Neurosurgery Hunterian Laboratories, Johns Hopkins Medical Institutions, Baltimore, MD, USA

Funder

Maryland Biotechnology Center Biotechnology Development Awards

Maryland Industrial Partnerships

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2020.1840971

Reference74 articles.

1. U.S. Food and Drug Administration. [cited 2019 Oct 22]. Available from: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedand.Approved/ApprovalApplications/AbbreviatedNewDrugApplicationANDAGenerics/default.htm

2. U.S. Food and Drug Administration. [cited 2019 Oct 22]. Available from: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/HowDrugsareDevelopedand.Approved/ApprovalApplications/NewDrugApplicationNDA/default.htm

3. U.S. Food and Drug Administration. [cited 2019 Oct 22]. Available from: https://www.fda.gov/science-research/science-and-research-special-topics/critical-path-initiative

4. U.S. Food and Drug Administration. [cited 2019 Oct 22]. Available from: https://www.fda.gov/Drugs/DevelopmentApprovalProcess/default.htm

5. Turning the Titanic

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long-Acting Opioid Analgesics for Acute Pain: Pharmacokinetic Evidence Reviewed;Veterinary Sciences;2023-05-24